Ticagrelor Versus Clopidogrel in Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

October 1, 2023

Study Completion Date

January 1, 2024

Conditions
Ischemic Stroke
Interventions
DRUG

Ticagrelor 90 MG Oral Tablet

Efficacy and safety of 180 mg loading dose of ticagrelor administered within 24 hours of first-ever ischemic stroke followed by 90 mg bid for 3 months will be assessed through NIHSS, mRS, duration of hospital stay, new ischemic stroke, and possible adverse effects.

DRUG

Clopidogrel tablet

efficacy and safety of 300 mg clopidogrel followed by 75 mg once daily for 3 months will be assessed through NIHSS, mRS, duration of hospital stay, new ischemic stroke and possible adverse effects.

Trial Locations (1)

6850001

Kafr Elsheikh University Hospital, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER